Clinical Trial Update: Effect of Vildagliptin Versus Dapagliflozin as Add on Therapy to Metformin on Cardiovascular Risk Factors [Phase 4]

View source ↗

Summary

Phase 4 trial comparing vildagliptin versus dapagliflozin as add-on to metformin in adults with type 2 diabetes evaluates cardiovascular risk factors. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)
• Galvus (vildagliptin)

Snippet

Sponsor: Al-Azhar University | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED